Patient perspectives on variant reclassification after cancer susceptibility testing
Colin M E Halverson1,2, Laurie M Connors3, Bronson C Wessinger4
1Center for Bioethics, Indiana University School of Medicine, Indianapolis, IN, USA.
Reclassified genetic test results rarely caused distress or decreased trust, but patients had trouble remembering the updated information. Improving communication about genetic testing changes is crucial for patient understanding.
Area of Science:
- Genetics
- Medical uncertainty
- Patient perception
Background:
- Impact of reclassification on patient trust in genetics-based care is unknown.
- Genetic test results can change, affecting patient management.
- Understanding patient perception of reclassified genetic tests is important.
Purpose of the Study:
- To investigate patient perceptions of reclassified genetic test results.
- To assess the impact on medical uncertainty and trust in genetic care.
- To evaluate patient recall of updated genetic test interpretations.
Main Methods:
- Conducted semistructured telephone interviews with 20 patients.
- Included patients with reclassified hereditary cancer genetic test results.
- Focused on patients tested within the last six years.
Main Results:
- Most patients did not report distress from reclassification.
- A minority of patients showed decreased trust in medical genetics.
- Recall of new genetic test interpretations was limited despite re-engagement.
Conclusions:
- Reclassification of genetic tests is a significant healthcare issue.
- Patients generally maintained trust despite result changes.
- Low comprehension and retention of updated genetic information highlight communication gaps.
- Further research is needed to enhance patient communication regarding reclassified results.
More Related Videos
13:24Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies
Published on: April 11, 2016
07:15Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation
Published on: January 16, 2019
Related Concept Videos
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Comparing Copy Number Variations and SNPs
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...
Cancer Survival Analysis
Cancer Prevention
Some...
